KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 118 filers reported holding KITE PHARMA INC in Q4 2014. The put-call ratio across all filers is 1.96 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,517,000 | +73.5% | 14,000 | 0.0% | 0.13% | +65.4% |
| Q2 2017 | $1,451,000 | +23.3% | 14,000 | -6.7% | 0.08% | +23.8% |
| Q1 2017 | $1,177,000 | +74.9% | 15,000 | 0.0% | 0.06% | +70.3% |
| Q4 2016 | $673,000 | -19.7% | 15,000 | 0.0% | 0.04% | -19.6% |
| Q3 2016 | $838,000 | +11.7% | 15,000 | 0.0% | 0.05% | +2.2% |
| Q2 2016 | $750,000 | +8.9% | 15,000 | 0.0% | 0.04% | +12.5% |
| Q1 2016 | $689,000 | -25.4% | 15,000 | 0.0% | 0.04% | -20.0% |
| Q4 2015 | $924,000 | +10.7% | 15,000 | 0.0% | 0.05% | +11.1% |
| Q3 2015 | $835,000 | +36.9% | 15,000 | +50.0% | 0.04% | +45.2% |
| Q2 2015 | $610,000 | +5.7% | 10,000 | 0.0% | 0.03% | +6.9% |
| Q1 2015 | $577,000 | 0.0% | 10,000 | 0.0% | 0.03% | -3.3% |
| Q4 2014 | $577,000 | – | 10,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |